| |
 |
ARTICLES 
|
|
| Dihydropyrimidine dehydrogenase activity and fluorouracil chemotherapy |
| RB Diasio and Z Lu |
|
JCO Nov 1 1994: 2239–2242.
[PDF]
|
 |
| The radical prostatectomy series: apples are not oranges |
| PW Kantoff and JA Talcott |
|
JCO Nov 1 1994: 2243–2245.
[PDF]
|
|
|
Population study of dihydropyrimidine dehydrogenase in cancer patients |
| |
MC Etienne, JL Lagrange, O Dassonville, R Fleming, A Thyss, N Renee, M Schneider, F Demard, and G Milano |
| |
JCO Nov 1 1994: 2248–2253.
[Abstract]
[PDF]
|
|
|
Radical prostatectomy for clinically localized prostate cancer: long- term results of 1,143 patients from a single institution |
| |
H Zincke, EJ Bergstralh, ML Blute, RP Myers, DM Barrett, MM Lieber, SK Martin, and JE Oesterling |
| |
JCO Nov 1 1994: 2254–2263.
[Abstract]
[PDF]
|
|
|
Significant activity of paclitaxel in advanced transitional-cell carcinoma of the urothelium: a phase II trial of the Eastern Cooperative Oncology Group |
| |
BJ Roth, R Dreicer, LH Einhorn, D Neuberg, DH Johnson, JL Smith, GR Hudes, SM Schultz, and PJ Loehrer |
| |
JCO Nov 1 1994: 2264–2270.
[Abstract]
[PDF]
|
|
|
Phase II trial of vinblastine, ifosfamide, and gallium combination chemotherapy in metastatic urothelial carcinoma |
| |
LH Einhorn, BJ Roth, R Ansari, R Dreicer, R Gonin, and PJ Loehrer |
| |
JCO Nov 1 1994: 2271–2276.
[Abstract]
[PDF]
|
|
|
Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumors |
| |
RJ Motzer, DF Bajorin, LH Schwartz, HS Hutter, GJ Bosl, HI Scher, P Lyn, and P Fischer |
| |
JCO Nov 1 1994: 2277–2283.
[Abstract]
[PDF]
|
|
|
Multiple atypical nevi: a cutaneous marker of germ cell tumors |
| |
D Raghavan, JR Zalcberg, JJ Grygiel, N Teriana, KM Cox, W McCarthy, and M Flynn |
| |
JCO Nov 1 1994: 2284–2287.
[Abstract]
[PDF]
|
|
|
Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma |
| |
N Kemeny, JA Conti, A Cohen, P Campana, Y Huang, WJ Shi, J Botet, S Pulliam, and JR Bertino |
| |
JCO Nov 1 1994: 2288–2295.
[Abstract]
[PDF]
|
|
|
Phase II trial of uracil and tegafur plus oral leucovorin: an effective oral regimen in the treatment of metastatic colorectal carcinoma |
| |
R Pazdur, Y Lassere, V Rhodes, JA Ajani, SM Sugarman, YZ Patt, DV Jones, Jr, AB Markowitz, JL Abbruzzese, and B Bready |
| |
JCO Nov 1 1994: 2296–2300.
[Abstract]
[PDF]
|
|
|
Phase II trial of docetaxel in patients with platinum-refractory advanced ovarian cancer |
| |
P Francis, J Schneider, L Hann, C Balmaceda, R Barakat, M Phillips, and T Hakes |
| |
JCO Nov 1 1994: 2301–2308.
[Abstract]
[PDF]
|
|
|
Squamous cell carcinoma antigen: prognostic significance and role in the monitoring of neoadjuvant chemotherapy response in cervical cancer |
| |
G Scambia, P Benedetti Panici, E Foti, M Amoroso, G Salerno, G Ferrandina, F Battaglia, S Greggi, A De Gaetano, and G Puglia |
| |
JCO Nov 1 1994: 2309–2316.
[Abstract]
[PDF]
|
|
|
Clinical impact of chemotherapy-induced thrombocytopenia in patients with gynecologic cancer |
| |
GL Goldberg, DG Gibbon, HO Smith, C DeVictoria, CD Runowicz, and ER Burns |
| |
JCO Nov 1 1994: 2317–2320.
[Abstract]
[PDF]
|
|
|
Phase III trial of recombinant interferon gamma in complete responders with small-cell lung cancer |
| |
JR Jett, AW Maksymiuk, JQ Su, JA Mailliard, JE Krook, LK Tschetter, CG Kardinal, DI Twito, R Levitt, and JB Gerstner |
| |
JCO Nov 1 1994: 2321–2326.
[Abstract]
[PDF]
|
|
|
Prophylactic cranial irradiation in complete responders with small-cell lung cancer: analysis of the Mayo Clinic and North Central Cancer Treatment Group data bases |
| |
EG Shaw, JQ Su, RT Eagan, JR Jett, AW Maksymiuk, and FA Deigert |
| |
JCO Nov 1 1994: 2327–2332.
[Abstract]
[PDF]
|
|
|
Drug delivery analysis of the Canadian multicenter trial in non-small- cell lung cancer |
| |
N Murray, C Coppin, A Coldman, J Pater, and E Rapp |
| |
JCO Nov 1 1994: 2333–2339.
[Abstract]
[PDF]
|
|
|
Postoperative radiation for lung cancer metastatic to the brain |
| |
JG Armstrong, M Wronski, J Galicich, E Arbit, SA Leibel, and M Burt |
| |
JCO Nov 1 1994: 2340–2344.
[Abstract]
[PDF]
|
|
|
Impact of postoperative radiation therapy and other perioperative factors on outcome after orthopedic stabilization of impending or pathologic fractures due to metastatic disease |
| |
PW Townsend, HG Rosenthal, SR Smalley, SC Cozad, and RE Hassanein |
| |
JCO Nov 1 1994: 2345–2350.
[Abstract]
[PDF]
|
|
|
Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer |
| |
EE Vokes, DJ Haraf, R Mick, JM McEvilly, and RR Weichselbaum |
| |
JCO Nov 1 1994: 2351–2359.
[Abstract]
[PDF]
|
|
|
Synovial sarcoma in children and adolescents: the St Jude Children's Research Hospital experience |
| |
AS Pappo, J Fontanesi, X Luo, BN Rao, DM Parham, C Hurwitz, L Avery, and CB Pratt |
| |
JCO Nov 1 1994: 2360–2366.
[Abstract]
[PDF]
|
|
|
Treatment of newly diagnosed children and adolescents with acute myeloid leukemia: a Childrens Cancer Group study |
| |
RJ Wells, WG Woods, JD Buckley, LF Odom, D Benjamin, I Bernstein, D Betcher, S Feig, T Kim, and F Ruymann |
| |
JCO Nov 1 1994: 2367–2377.
[Abstract]
[PDF]
|
|
|
The Pediatric Oncology Group experience with the international staging system criteria for neuroblastoma. Member Institutions of the Pediatric Oncology Group |
| |
RP Castleberry, JJ Shuster, and EI Smith |
| |
JCO Nov 1 1994: 2378–2381.
[Abstract]
[PDF]
|
|
|
Allogeneic versus autologous purged bone marrow transplantation for neuroblastoma: a report from the Childrens Cancer Group |
| |
KK Matthay, RC Seeger, CP Reynolds, DO Stram, MC O'Leary, RE Harris, M Selch, JB Atkinson, GM Haase, and NK Ramsay |
| |
JCO Nov 1 1994: 2382–2389.
[Abstract]
[PDF]
|
|
|
Altered etoposide pharmacokinetics and time to engraftment in pediatric patients undergoing autologous bone marrow transplantation |
| |
JH Rodman, DJ Murry, T Madden, and VM Santana |
| |
JCO Nov 1 1994: 2390–2397.
[Abstract]
[PDF]
|
|
|
Immunoglobulin D multiple myeloma: presenting features, response to therapy, and survival in a series of 53 cases |
| |
J Blade, JA Lust, and RA Kyle |
| |
JCO Nov 1 1994: 2398–2404.
[Abstract]
[PDF]
|
|
|
Combination chemotherapy, glucocorticoids, and interferon alfa in the treatment of multiple myeloma: a Southwest Oncology Group study |
| |
SE Salmon, JJ Crowley, TM Grogan, P Finley, RP Pugh, and B Barlogie |
| |
JCO Nov 1 1994: 2405–2414.
[Abstract]
[PDF]
|
|
|
Autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma and CNS involvement: those transplanted with active CNS disease have a poor outcome--a report by the European Bone Marrow Transplant Lymphoma Registry |
| |
CD Williams, R Pearce, G Taghipour, ES Green, T Philip, and AH Goldstone |
| |
JCO Nov 1 1994: 2415–2422.
[Abstract]
[PDF]
|
|
|
Phase I/II study of cyclophosphamide, carboplatin, and etoposide and autologous hematopoietic stem-cell transplantation with posttransplant interferon alfa-2b for patients with lymphoma and Hodgkin's disease |
| |
DP Schenkein, P Dixon, JF Desforges, E Berkman, JK Erban, JL Ascensao, and KB Miller |
| |
JCO Nov 1 1994: 2423–2431.
[Abstract]
[PDF]
|
|
|
Randomized double-blind, placebo-controlled evaluation of oral ondansetron in the prevention of nausea and vomiting associated with fractionated total-body irradiation |
| |
TR Spitzer, JC Bryson, E Cirenza, R Foelber, M Wallerstadt, C Stout, RL Kunka, PB Plagge, and A Dubois |
| |
JCO Nov 1 1994: 2432–2438.
[Abstract]
[PDF]
|
|
|
Optimal combination therapy with tropisetron in 445 patients with incomplete control of chemotherapy-induced nausea and vomiting |
| |
F Hulstaert, S Van Belle, H Bleiberg, JL Canon, M Dewitte, M Buyse, P De Keyser, and KJ Westelinck |
| |
JCO Nov 1 1994: 2439–2446.
[Abstract]
[PDF]
|
|
|
Treatment tolerance of elderly cancer patients entered onto phase II clinical trials: an Illinois Cancer Center study |
| |
S Giovanazzi-Bannon, A Rademaker, G Lai, and AB Benson, 3rd |
| |
JCO Nov 1 1994: 2447–2452.
[Abstract]
[PDF]
|
|
|
Multidrug resistance in lymphomas |
| |
AR Yuen and BI Sikic |
| |
JCO Nov 1 1994: 2453–2459.
[Abstract]
[PDF]
|
|
|
Current perspectives on aromatase inhibitors in breast cancer |
| |
PE Goss and KM Gwyn |
| |
JCO Nov 1 1994: 2460–2470.
[Abstract]
[PDF]
|
|
|
American Society of Clinical Oncology. Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines |
| |
|
| |
JCO Nov 1 1994: 2471–2508.
[Abstract]
[PDF]
|
|
| ASCO 30 years later: the state of the Society |
| GP Canellos |
|
JCO Nov 1 1994: 2510–2513.
[PDF]
|
|
| Therapy-related leukemia associated with high-dose 4-epi-doxorubicin and cyclophosphamide used as adjuvant chemotherapy for breast cancer |
| L Shepherd, J Ottaway, J Myles, and M Levine |
|
JCO Nov 1 1994: 2514–2515.
[PDF]
|
|
| Tamoxifen versus medroxyprogesterone acetate for metastatic breast cancer |
| CD Atkins |
|
JCO Nov 1 1994: 2515–2516.
[PDF]
|
|
| bcl-2 evaluation in patients in long-term complete remission after bone marrow transplantation |
| P Colombat, MA Garrigue, JP Lamagnere, JP Muh, and C Linassier |
|
JCO Nov 1 1994: 2516a.
[PDF]
|
|
| Outpatient antibiotic therapy in febrile neutropenic patients undergoing high-dose chemotherapy and autologous bone marrow support |
| EB Rubenstein, K Rolston, and L Elting |
|
JCO Nov 1 1994: 2516b–2517.
[PDF]
|
|
| Use of parenteral antibiotics in neutropenic patients |
| FA Manian and DA Janssen |
|
JCO Nov 1 1994: 2517–2519.
[PDF]
|
|
| Anticancer antibodies for lung cancer |
| MJ Kelley and JL Mulshine |
|
JCO Nov 1 1994: 2519–2520.
[PDF]
|
|
| Dosing error in protocol book |
| RT Dorr and D Lauper |
|
JCO Nov 1 1994: 2520.
[PDF]
|
|
